Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: November 2022

Workgroups: Access to Health Services Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends against using combined estrogen and progestin to prevent chronic conditions in postmenopausal people. For people who have gone through menopause and had a hysterectomy, USPSTF recommends against using estrogen alone to prevent chronic conditions. USPSTF has made other recommendations to prevent chronic conditions in adults, which include:

Read more about this resource

Objectives related to this resource (1)

Increase the proportion of adults who get recommended evidence-based preventive health care — AHS‑08
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2022). Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication.